MK Proteins Limited has submitted its quarterly compliance certificate to stock exchanges for the quarter ended March 31, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulation, 2018.

Regulatory Compliance Filing

The company filed the mandatory certificate with both Bombay Stock Exchange Limited and National Stock Exchange of India Limited on April 10, 2026. The submission was signed by Managing Director Parmod Kumar (DIN: 00126965) and addressed the compliance requirements under Regulation 74(5) of SEBI regulations.

Share Transfer Agent Confirmation

Bigshare Services Private Limited, the company's registrar and share transfer agent, issued a certificate dated April 4, 2026, confirming the non-applicability of certain SEBI regulations. The RTA holds SEBI Registration No INR000001385 and serves as the official registrar for MK Proteins Limited.

The certificate specifically addressed Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018, which was previously known as Regulation 54 of SEBI (Depository and Participant) Regulations, 1996.

Dematerialisation Status

According to the RTA's certificate, the regulation was not applicable to MK Proteins Limited during Q4FY26 due to specific operational circumstances. The key findings include:

• Entire shareholding of the company remains in dematerialised form
• No requests received from shareholders for rematerialisation during the quarter
• No requests received from shareholders for dematerialisation during the quarter
• Complete digital share management maintained throughout Q4FY26

Corporate Information

MK Proteins Limited operates from its registered office at Naraingarh Road, Village Garnala, Ambala City, Haryana. The company trades on stock exchanges under scrip code 543919 on BSE and symbol MKPL on NSE. The filing demonstrates the company's commitment to maintaining regulatory compliance and transparent shareholder communication.

MK Proteins Limited has delivered impressive financial performance in Q3FY26, demonstrating strong operational growth across key metrics. The vegetable refined oil manufacturer reported substantial revenue expansion and maintained healthy profitability during the quarter ended December 31, 2025.

Financial Performance Overview

The company's quarterly results showcase remarkable revenue growth, with operations scaling significantly compared to the previous year. Total revenue including other income reached ₹8957.54 lacs in Q3FY26, representing a substantial increase from ₹3972.44 lacs in Q3FY25.

Operational Efficiency and Cost Management

The company's expenditure structure reflects the scaled operations, with total expenses rising to ₹8760.91 lacs in Q3FY26 from ₹3786.57 lacs in Q3FY25. Key expense components included cost of material consumed at ₹8569.66 lacs and purchase of stock-in-trade at ₹2569.96 lacs. Notably, the company benefited from a favorable change in inventories of ₹2734.84 lacs, which positively impacted the overall cost structure.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, MK Proteins demonstrated consistent growth momentum. Revenue from operations increased to ₹23693.46 lacs compared to ₹13050.19 lacs in the corresponding period of FY25. Net profit for nine months reached ₹569.07 lacs, marginally higher than ₹560.13 lacs achieved in 9MFY25.

Earnings Per Share and Capital Structure

The company maintained stable earnings per share metrics during the quarter. Basic and diluted earnings per share from continuing operations stood at ₹0.04 for Q3FY26, matching the ₹0.04 achieved in Q3FY25. The paid-up equity share capital remained unchanged at ₹3753.72 lacs with a face value of ₹1 per share.

Corporate Governance and Compliance

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 13, 2026. The results have been reviewed by statutory auditors Subhash Sajal & Associates as required under Regulation 33 of SEBI Listing Regulations. The company operates in a single business segment focused on manufacturing vegetable refined oil, with no separate reportable segments.